The enhanced monofocal TECNIS Eyhance IOL (ICB00) cannot
be visually distinguished from the TECNIS 1-Piece IOL (ZCB00), said Prof.
Gerd Auffarth, chairman of the Department of Ophthalmology, Ruprecht-Karls University of Heidelberg, Germany.
The Eyhance IOL has a refractive optical design with a high-order aspheric anterior surface that creates a continuous power progression.
This refractive profile increases the power of the enhanced monofocal IOL continuously from the periphery to the center of the lens to extend the depth of focus.
Plus, the higher order aspheric design of the Eyhance IOL at the same time compensates corneal spherical aberrations of -0.27 microns.
Results from a multicenter European prospective randomized study comparing the Eyhance ICB00 ลาวสามัคคี
and the 1-Piece ZCB00 IOLs showed that the Eyhance outperforms the standard monofocal lens.
Patients enrolled in the trial were assigned to undergo bilateral implantation with the enhanced monofocal IOL or the standard monofocal lens.
Sixty-seven (67) subjects who received the enhanced monofocal lens and 72 in the standard monofocal IOL group were seen at a 6-month follow-up visit.
Data showed that the TECNIS Eyhance IOL provided statistically significant improvement in monocular intermediate vision at 66cm.
To conclude, he said in comparison to aspheric monofocal IOLs, patients benefited from the TECNIS Eyhance IOL thanks to enhanced intermediate visual acuity. Because of its extended depth of focus, Better vision low-risk
TECNIS Eyhance also appears to have a broader refractive landing zone compared with a standard monofocal IOL.
He further noted that all of the benefits from the hydrophobic material of the TECNIS IOL platform also remained unchanged.
“There was no glistening, no light scattering, nor risk of calcification due to hydrophilic materials,” shared Prof.
Auffarth. Benefits for patients with retinal disorders The TECNIS Eyhance can provide an improvement in intermediate vision, not only in normal cases,
but also in cases of cataract surgery performed on patients with various retinal conditions, said Better vision low-risk
Dr. Dong Yoon Kim, chief surgeon, Top Retina Center, Seoul, Korea.
For more information: ลาวสามัคคี